Latest Astellas Pharma Stories
HERSHEY, Pa., Rockville, Md. and TOKYO, Jan. 29, 2015 /PRNewswire/ -- Immunomic Therapeutics, Inc.
NORTHBROOK, Ill., Jan. 22, 2015 /PRNewswire/ -- Astellas today announced that the U.S.
TOKYO, Jan. 15, 2015 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas," Tokyo: 4503) today announced that Eric Terhaerdt has been named senior vice president of Global Development Operations.
DUBLIN, Ohio, Jan. 7, 2015 /PRNewswire-USNewswire/ -- Astellas Pharma US, Inc.
ReportsnReports.com adds “Heart Transplantation - Pipeline Review, H2 2014” to its store.
NORTHBROOK, Ill., Dec. 18, 2014 /PRNewswire/ -- Astellas US LLC today announced that the Company's global President and CEO Yoshihiko Hatanaka will present at the 33(rd) Annual J.P.
DUBLIN, Nov. 24, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has agreed to market the authorized generic version of Astellas U.S.
Focus on research and development for small molecule inhibitors of oncogenic K-Ras - the most commonly mutated oncogene in human cancers BOSTON and TOKYO, Nov.
More than 6,000 employees worldwide have already completed over 13,000 hours of volunteer service in their communities TOKYO, Nov. 4, 2014 /PRNewswire/ -- Astellas Pharma Inc.
HILDEN, Germany and TOKYO, October 28, 2014 /PRNewswire/ -- - First two programs aim to create tests to aid in cancer treatment with Astellas compounds
- The word or words serving to define another word or expression, as in a dictionary entry.